Skip to main content

Table 1 Clinical characteristics of participants

From: MicroRNA-146a rs2910164 is associated with severe preeclampsia in Black South African women on HAART

Variable

PE Total (n = 97)

Normo Total

(n = 95)

PE HIV-

(n = 53)

PE HIV+

(n = 44)

Normo HIV–

(n = 50)

Normo HIV+

(n = 45)

p value

Mean age (mean ± SEM)

26.6 ± 0.668

26.2 ± 0.673

24.8 ± 0.723

28.7 ± 1.108

24.6 ± 0.904

28.0 ± 0.947

0.708a

0.002 b, d, f

0.6081c

Age range (years)

16–42

16–46

16–40

16–42

16–42

17–46

Parity n (%)

 0

44 (45)

22 (23)

26 (49)

18 (41)

17 (34)

5 (11)

0.006b

 1–5

53 (55)

70 (74)

27 (50)

26 (59)

31 (62)

39 (87)

0.400c

  > 5

1 (1.1)

3 (3.2)

0 (0.0)

1 (2.2)

2 (4.0)

1 (2.2)

 

Mean CD4 (x106/l) (n)

447 ± 28.2 (44)

427 ± 31.1 (47)

670 ± 154 (2)

437 ± 28.0 (42)

399 ± 66.9 (7)

432 ± 34.9 (40)

0.6346a

0.431b

0.9212c

BMI (n)

31.5 ± 0.847 (73)

30.0 ± 0.889 (71)

30.4 ± 1.30 (35)

32.5 ± 1.10 (38)

29.8 ± 1.22 (35)

30.2 ± 1.30 (36)

0.2126a

0.2148b

0.179c

MOD n (%)

      

<0.001b

 ELCS

18 (19)

52 (55)

9 (17)

9 (20)

25 (50)

27 (60)

<0.001c

 EMCS

55 (56)

24 (25)

32 (60)

23 (52)

13 (26)

11 (24)

 

 NVD

24 (25)

15 (16)

12 (23)

12 (27)

9 (18)

6 (13)

 TOTAL

97 (100)

91 (96)

53 (100)

44 (100)

47 (94)

44 (98)

Blood Pressure (n)

- Systolic

158 ± 1.75 (86)

119 ± 1.32 (62)

157 ± 17.2 (50)

159 ± 2.17 N = 43

119 ± 8.81 (29)

119 ± 2.03 (33)

<.0.0001a

<.0.0001b, e, f, g, h

<.0.0001c

- Diastolic

103 ± 1.24 (93)

74.7 ± 1.11 (62)

102 ± 13.5 (50)

104 ± 1.51 (43)

73.9 ± 8.76 (29)

75.3 ± 1.53 (33)

<.0.0001a

<.0.0001b, e, f, g, h

<.0.0001c

Severe PE (%)

  

18 (34)

21 (48)

  

0.121b

EOPE (%)

  

14 (26)

18 (40)

  

0.143b

Cytokines

IL-2 (n)

265 ± 3.57 (17)

270 ± 0.949 (59)

273 ± 4.76 (7)

260 ± 4.59 (10)

274 ± 1.24 (29)

267 ± 1.21 (30)

0.1827a

0.006b, d, f

0.164 c

IL-4 (n)

251 ± 5.40 (18)

244 ± 1.90 (59)

258 ± 26.7 (8)

245 ± 5.97 (10)

248 ± 16.4 (29)

241 ± 2.14 (30)

0.2537a

0.0579b

0.4760c

IL-6 (n)

150 ± 8.28 (18)

152 ± 4.29 (59)

174 ± 36.5 (7)

136 ± 7.90 (11)

154 ± 28.1 (29)

150 ± 6.83 (30)

0.8938a

0.0057b

0.1920c

IL-10 (n)

138 ± 46.0 (16)

81.7 ± 10.2 (54)

237 ± 251 (7)

61.4 ± 10.5 (9)

95.9 ± 68.0 (29)

66.4 ± 15.8 (26)

0.249a

0.085b

IL-17a (n)

1520 ± 311 (16)

800 ± 31.5 (58)

785 ± 118 (8)

2250 ± 509 (8)

773 ± 36.2 (29)

827 ± 62.9 (29)

0.036a

<0.0001b, f, h, i

0.027c

TNF-α (n)

186 ± 12.4 (19)

175 ± 4.01 (60)

203 ± 72.7 (8)

173 ± 10.3 (11)

186 ± 15.6 (29)

164 ± 6.78 (31)

0.416a

0.0008b, d, g

0.479c

IFN-γ (n)

214 ± 11.1 (18)

281 ± 64.7 (60)

221 ± 70.5 (8)

209 ± 4.82 (10)

221 ± 15.4 (29)

336 ± 125 (31)

0.317a

0.036b

0.319c

  1. Means represented as mean ± SEM (n)
  2. Abbreviations: GA gestational age, BMI Body Mass Index, MOD mode of delivery, ELCS elective caesarean section, EMCS emergency caesarean section, NVD normal vaginal delivery, SEM standard error of mean, PE preeclampsia, NORMO normotensive, n total number, p is significant at <0.05
  3. aComparison between NORMO and PE
  4. bComparison amongst all four sub-groups (or between PE HIV- vs PE HIV+ for Severe PE and EOPE)
  5. cComparison between PE HIV+ and NORMO HIV+
  6. dAd-hoc test between Normo HIV – and Normo HIV +
  7. eAd-hoc test between Normo HIV – and PE HIV -
  8. fAd-hoc test between Normo HIV – and PE HIV +
  9. gAd-hoc test between Normo HIV + and PE HIV -
  10. hAd-hoc test between Normo HIV + and PE HIV +
  11. iAd-hoc test between PE HIV – and PE HIV +